Tiny bugs, big clues: Crohn's surgery study peers inside the gut
NCT ID NCT06146335
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at 11 adults with Crohn's disease who had surgery to remove damaged parts of their intestine. Researchers compared two surgical methods—Kono-S and standard side-to-side—to see how each affected the gut's bacteria and immune cells. The goal was to gather clues about why some surgeries work better than others, not to test a new treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
11 people
The number who actually took part.
- Started
-
Jan 2024
- Finished
-
May 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: 1. Patients with Crohn's ileitis/ileocolitis requiring surgical resection OR patients previously enrolled in the "Kono-S anastomosis versus side-to-side functional end anastomosis in the prevention of post-operative recurrence of Crohn's Disease (WC IRB #1303013645)" trial. 2. Patients age 18 years and older. 3. All phenotypes will be included: nonstricturing nonpenetrating (B1), stricturing (B2), and penetrating (B3) according to the Vienna classification. 4. Patients will be included regardless of preoperative medications (untreated, steroids, biologics) Exclusion Criteria: 1. Patients under 18 years of age. 2. Pregnant patients. 3. Patient does not speak English 4. Patients that may need a different surgical procedure as per the surgeon at the time of intraoperative evaluation
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Crohn disease are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Weill Cornell Medical Center
New York, New York, 10065, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Mini-Guts in a dish: scientists probe why IBD tissue struggles to heal
- Can immune aging blood tests predict which older IBD patients thrive on advanced therapies?
- Can a liquid diet calm Crohn's in kids?
- Which IBD therapy works best for kids? researchers compare two approaches
- Can trained peer mentors ease the mental toll of IBD?
- Can a new pill tame inflammatory bowel disease?